TOLVAPTAN ZENTIVA 30 mg, tablet + tolvaptan zentiva 90 mg, tablet 56 tablets
Active ingredients: Tolvaptan
Commercialized according to BDPMDispensing in France: Prescription only
Tablet56 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TOLVAPTAN ZENTIVA 30 mg, comprimé + TOLVAPTAN ZENTIVA 90 mg, comprimé
- Pharmaceutical form
- comprimé et comprimé
- Route of administration
- orale
- Presentation description
- 56 comprimés sous plaquettes (Alu/PVC/Alu/OPA) de 4 x 14 comprimés (7 comprimés de 90 mg et 7 comprimés de 30 mg)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 30 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 15 Dec 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a hospital doctor
- Initial prescription by a specialist
- Renewal by a specialist only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65920174CIP73031766CIP133400930317662Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TOLVAPTANcomprimé 30 mg | 30 mg · un comprimé | SA |
| TOLVAPTANcomprimé 90 mg | 90 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.